← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Epigenx Pharmaceuticals
Santa Barbara, CA
$2,410,181
Total funding
7
Grants
Funding mix
By agency
NIH$2,410,181 · 7
By mechanism
R44$1,364,975 · 2
R43$1,045,206 · 5
Investigators at Epigenx Pharmaceuticals
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of Inhibitors of the DNA Methylation Process$377,700
R44 · FY2003 · CA
Development of DAM Inhibitors as Novel Antibiotics$375,790
R44 · FY2003 · AI
Development of DAM Inhibitors as Novel Antibiotics$344,474
R44 · FY2004 · AI
Development of Inhibitors of the DNA Methylation Process$251,011
R44 · FY2004 · CA
Development of DNA Methyltransferase Inhibitors as Anti*$227,827
R43 · FY2002 · CA
Development of DNA Methyltransferase Inhibitors as Anti*$227,827
R43 · FY2003 · CA
DEVELOPMENT OF INHIBITORS OF THE DNA METHYLATION PROCESS$165,206
R43 · FY2001 · CA
DAM Inhibitors: A new class of antibiotics$121,178
R43 · FY2001 · AI
Whole Genome Methylation Assay$103,000
R43 · FY2002 · CA
Technology for Genome-Wide Cancer Methylation Profiling$100,168
R43 · FY2002 · CA
Whole Genome Methylation Assay$100,000
R43 · FY2001 · CA
Development of Inhibitors of the DNA Methylation Process$16,000
R44 · FY2004 · CA